Erratum to: Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer

Παρόμοια τεκμήρια

• Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer
  ανά: Stopeck, Alison T., κ.ά.
  Έκδοση: (2015)
• Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
  ανά: Fizazi, Karim, κ.ά.
  Έκδοση: (2011)
• Denosumab and Bone Metastasis-Free Survival in Men With Castration-Resistant Prostate Cancer: Results of a Global Phase 3, Randomised, Placebo-Controlled Trial
  ανά: Smith, Matthew R, κ.ά.
  Έκδοση: (2011)
• Impact of denosumab on bone mass in cancer patients
  ανά: Brown-Glaberman, Ursa, κ.ά.
  Έκδοση: (2013)
• Response to letter to the Editors—Safety of long-term denosumab therapy
  ανά: Stopeck, Alison T., κ.ά.
  Έκδοση: (2016)